Free Shipping on purchases over €100

Sesderma VITISes Kt 125 ml

Sesderma VITISes Kt 125 ml

Sesderma Vitises KT 125ml is a lotion that accelerates skin pigmentation by helping to regulate melanin levels in the skin. It can be used in natural or artificial exposure to UV rays.

SKU: 153549
Sold out
45.00
€57.05
Temporarily sold out

Subscribe and we will notify you when it becomes available again.

Pharmaceutical Care

Safe medication sales

Secure shipping

PHARMACEUTICAL RECOMMENDATION

License Number: 7270

Silvia Del Río

A pharmacist specializing in dermocosmetics, skin microbiota, and hygiene will advise and help you with the most suitable treatment.

Ask me

INFO AND TECHNICAL SPECIFICATIONS

 

Sesderma Vitises KT 125ml

This is a lotion that restores normal melanin levels in the skin of the face and body, unifying its tone, thanks to its active ingredients of kellin and phenylalanine encapsulated in nanosomes, which act by accelerating pigmentation in the melanocytes.

 

Who is it indicated for?

It is a product indicated for the treatment of hypopigmented skin.


Advantages

It has antioxidant properties that protect the skin from oxidative damage.

Restores melanin levels in the skin.

Can be combined with narrowband UVB.


How to use

Spray Sesderma Vitises KT 125ml onto depigmented skin about 30 minutes before sun exposure.


Pharmacist recommendations

Store in a cool, dry place out of the reach of children.

Product for external use, so avoid contact with eyes. In case of contact, rinse with plenty of water.


Composition

The active ingredients of this product are: Kellin and Phenylalanine encapsulated in liposomes.

Tecnical specifications card

Pharmaceutical advice

You can now consult our team with any questions you may have. We remind you that our chatbot is also available for simpler queries.

Ask us
  • Vendor: Sesderma S.L.
  • Vendor address: Calle Mar Mediterrania (Polígono Industrial Torre del Rector), 5-9, 08130 Santa Perpètua de Mogoda, Barcelona, España
  • Phone number: +34 935 747 440
Newsletter

Don’t miss anything

Stay up to date with the latest advances in health, discounts, and pharmaceutical news.